National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES

1966 No. 144

________

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1966.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1966.

Dated this twentieth day of October, 1966.

CASEY

Governor-General.

By His Excellency’s Command,

(Signed) A. G. Forbes

Minister of State for Health.

________

Amendments of the National Health (Pharmaceutical Benefits) Regulations 

Commencement.

1.These Regulations shall come into operation on the first day of November, 1966.

First Schedule.

2. The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by omitting the words—

“ Botulinum Antitoxin.”;

(b) by omitting the words—

“ Dichloralphenazone Tablets.”;

(c) by omitting the words—

“ Guanethidine Sulphate.”;

(d) by inserting after the words—

“ Chloroquine Phosphate.”

the words—

“ Chloroquine Phosphate Injection.”;

______________________________________________________________________

* Notified in the Commonwealth Gazette on  , 1966.

  Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; 1965, Nos. 51, 151 and 152; and 1966, No. 80.

10467/66.—Price 25c (2s. 6d.) 9/13.10.1966

(e) by inserting after the words—

“ Magnesium Stearate.”

the words—

“ Maize Oil.”;

(f) by omitting the word—

“ Mannitol.”;

(g) by inserting after the word—

“ Picrotoxin.”

the words—

“ Picrotoxin Injection.”;

(h) by inserting after the words—

“ Rabies Vaccine.”

the word—

“ Santonin.”; and

(i) by omitting the words—

“ Trifluoperazine Hydrochloride.”.

Secondand Third Schedules.

3. The Second and Third Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

SECOND SCHEDULE Regulation 10 (3.).

Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations

Pharmaceutical Benefits	Allowable Compounds (if any)
Acrylic Resin...............................................	__
Aluminium Powder, B.P.C.........................	Aluminium Powder B.P.C. with Liquid Paraffin B.P. and Zinc Oxide Ointment B.P.
Aluminium Sodium Silicate........................	Aluminium Sodium Silicate with Belladonna
Amphotericin B...........................................	Tetracycline with a buffering agent and Amphotericin B.
Aneurine Hydrochloride, B.P......................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Antazoline Sulphate....................................	Antazoline Sulphate with Naphazoline Nitrate B.P.
Ascorbic Acid, B.P......................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Attapulgite...................................................	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
Bacitracin, B.P............................................	Polymyxin B Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Betamethasone Disodium Phosphate..........	—
Betamethasone Phosphate...........................	—
Brompheniramine Maleate .........................	—
Calciferol.....................................................	—
Calcium Lactobionate.................................	Thenalidine with Calcium Lactobionate
Carbachol, B.P............................................	—
Carbinoxamine Maleate..............................	—
Carbromal, B.P............................................	Carbromal B.P., with Pentobarbitone Sodium B.P.
Chloramine, B.P.C......................................	—
Chloramphenicol, B.P.................................	Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Chlorhexidine Gluconate ..............................	—
Chlorpheniramine Maleate, B.P......................	—
Chlorpromazine Hydrochloride, B.P...............	—
Chlortetracycline Hydrochloride, B.P.............	—
Clemizole Tannate........................................	—
Cortisone Acetate, B.P...................................	—
Cymogran.....................................................	—
Cyproheptadine Hydrochloride......................	—
Cyclizine Hydrochloride, B.P.........................	Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
Demecarium Bromide...................................	—
Demethylchlortetracycline Hydrochloride, B	Demethylchlortetracycline Hydrochloride B.P. with Nystatin B.P.
Dexchlorpheniramine Maleate.......................	—
Dextran........................................................	Dextran with Dextrose B.P.
Dextran in Normal Saline
Dicyclomine Hydrochloride, B.P.C................	—
Dienoestrol, B.P............................................	—
Digoxin, B.P.................................................	—
Dihydrostreptomycin Sulphate, B.P. 1958.......	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
Dihydrostreptomycin Sulphate B.P. 1958 with Kaolin, Pectin and Aluminium Hydroxide Gel
Dihydrotachysterol........................................	—
Dimethicone.................................................	—
Diphenhydramine Hydrochloride, B.P............	Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
Diphenylpyraline Hydrochloride....................	—
Diphtheria Vaccine, B.P................................	Diphtheria and Tetanus Vaccine B.P.
Diphtheria, Tetanus and Pertussis Vaccine B.P.
Dyflos, B.P.C................................................	—
Ecothiopate Iodide........................................	—
Entsufon.......................................................	Hexachlorophane B.P. with Entsufon
Ergometrine Maleate.....................................	Oxytocin with Ergometrine Maleate
Ergotamine Tartrate, B.P...............................	Ergotamine Tartrate B.P. with Caffeine B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
Erythromycin Oral Suspensions and Syrups	—
Erythromycin Paediatric Drops......................	—
Ethosuximide................................................	—
Ferric Hydroxide...........................................	—
Ferrous Aminoacetosulphate..........................	—
Ferrous Succinate..........................................	—
Framycetin Sulphate......................................	—
Fusidic Acid (Diethanolamine Salt)	—
Galactomin...................................................	—
Glucose Indicator..........................................	—
Glyceryl Guaiacolate.....................................	Theophylline with Glyceryl Guaiacolate
Gramicidin...................................................	Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Hamamelis Dry Extract, B.P.C.......................	Hamamelis Dry Extract B.P.C. with Zinc Oxide B.P.
Hexachlorophane, B.P...................................	Hexachlorophane B.P. with Entsufon
Hexachlorophane B.P. with Lissapol
Hexachlorophane B.P. in Soap Solution
Hydrocortisone, B.P......................................	—
Hydrocortisone Acetate, B.P..........................	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Idoxuridine...................................................	—
Ipecacuanha, B.P...........................................	Phenolphthalein B.P. with Aloin B.P.C., Dry Extract of Belladonna B.P., Strychnine B.P.C. 1959 and Ipecacuanha B.P.
Isoprenaline Hydrochloride............................	—
Kanamycin Sulphate, B.P.C...........................	—
Levallorphan Tartrate, B.P.............................	Levallorphan Tartrate B.P. with Pethidine Hydrochloride B.P.
Lissapol........................................................	Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P.
Hexachlorophane B.P. with Lissapol
Lofenalac.....................................................	—
Magnesium Chloride.....................................	Ammonium Chloride B.P. with Sodium Chloride B.P., Potassium Chloride B.P. and Magnesium Chloride
Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P.
Mebhydrolin Napadisylate, B.P.C..................	—
Meclozine Hydrochloride, B.P.......................	Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
Mepyramine Maleate, B.P.............................	—
Methacycline................................................	—
Methdilazine Hydrochloride..........................	—
Methenamine Mandelate................................	—
Methyl Glucamine.........................................	Theophylline B.P. with Methyl Glucamine
Minafen........................................................	—
Morphine Tartrate.........................................	Morphine Tartrate with Tacrine
Naphazoline Nitrate, B.P...............................	Naphazoline Nitrate B.P. with Antazoline Sulphate
Neomycin Sulphate, B.P................................	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Polymyxin B. Sulphate B. P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Neomycin Sulphate B.P. with Kaolin B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Neostigmine Methylsulphate, B.P..................	—
Neutramigen.................................................	—
Nicotinamide, B.P.........................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Nitrofurantoin, B.P........................................	—
Nortriptyline Hydrochloride...........................	—
Nystatin, B.P.................................................	Tetracycline with a buffering agent and Nystatin B.P.
Oxytetracycline Hydrochloride B.P. with a buffering agent and Nystatin B.P.
Demethylchlortetracycline Hydrochloride B.P. with Nystatin B.P.
Oxytetracycline Hydrochloride, B.P...............	Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P.
Oxytetracycline Hydrochloride B.P. with a buffering agent and Nystatin B.P.
Oxytocin......................................................	Oxytocin with Ergometrine Maleate

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Pancreatin Enzyme, U.S.N.F. XI....................	—
Papaveretum, B.P.C......................................	Papaveretum B.P.C. with Hyoscine Hydrobromide B.P.
Penicillin, Benethamine, B.P.C......................	Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Penicillin, Benzathine, B.P.............................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Penicillin, Benzyl, B.P...................................	Penicillin, Benzyl B.P. with Streptomycin Sulphate B.P.
Fortified Procaine Penicillin Injection B.P.
Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Penicillin, Phenoxymethyl (Benzathine, Calcium, Hydrabamine or Potassium Salt or Free Acid)..................................................	—
Penicillin, Potassium, B.P..............................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Penicillin, Procaine, B.P................................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Fortified Procaine Penicillin Injection B.P.
Penicillin, Benethamine B.P.C. with Procaine Pencillin B.P. and Sodium Penicillin B.P.
Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Penicillin, Sodium, B.P..................................	Penicillin, Benethamine B.P. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Pentolinium Tartrate, B.P...............................	Pentolinium Tartrate B.P. with Ephedrine Hydrochloride B.P.
Pertussis Vaccine, B.P...................................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Pethidine Hydrochloride, B.P.........................	Pethidine Hydrochloride B.P. with Levallorphan Tartrate B.P.
Pethidine Hydrochloride B.P. with Scopolamine Hydrobromide B.P.
Phenethicillin Potassium................................	—
Pheniramine Maleate.....................................	—
Phenytoin.....................................................	—
Pilocarpine Hydrochloride.............................	—
Pipenzolate Methobromide............................	—
Pituitary (Posterior Lobe), Powdered, B.P.C.	—
Polymyxin B. Sulphate, B.P...........................	Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.
Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P.
Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Polymyxin B. Sulphate B.P. with Propylene Glycol and Acetic acid
Methylprednisolone, B.P...............................	—
Prednisolone Sodium Hemisulphate...............	—
Prednisolone Sodium Phosphate, B.P.C..........	—
Prednisolone Trimethylacetate, B.P................	—
Promethazine Hydrochloride, B.P..................	—
Riboflavine, B.P............................................	Vitamin A with Anuerine Hydrochloride B.P. Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D.
Senna Fruit, B.P............................................	—
Silver Nitrate, Toughened, B. P......................	—
Sobee...........................................................	—

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Sodium Lactate.............................................	Sodium Lactate with Potassium Chloride B.P. and Sodium Chloride B.P.
Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P.
Sodium Lactate with Sodium Chloride B.P. and Dextrose B.P.
Sodium Lactate with Sodium Chloride B.P.
Sodium Lactate with Potassium Chloride B.P. and Dextrose B.P.
Sodium Potassium Tartrate, B.P.C..................	Compound Effervescent Powder B.P.C.
Sodium Tauroglycocholate, B.P.C. 1954.........	Sodium Tauroglycocholate B.P.C. 1954 with Cascara Dry Extract B.P.
Spearmint Oil, B.P.C.....................................	Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P.
Strychnine, B.P.C. 1959................................	Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine B.P.C. 1959 and Ipecacuanha
Sulphacetamide, B.P.C..................................	Sulphacetamide B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
Sulphafurazole, B.P.......................................	—
Sulphamerazine, B.P. 1958............................	Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphathiazole B.P.C.
Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphacetamide B.P.C.
Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphadimidine B.P.
Sulphamethoxazole.......................................	—
Sulphaphenazole, B.P.C................................	—
Sulphathiazole, B.P.C....................................	Sulphathiazole B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
Surgical Cement............................................	—
Surgical Cement Solvent...............................	—
Tacrine.........................................................	Morphine Sulphate B.P. with Tacrine
Morphine Tartrate with Tacrine
Tetanus Vaccine, B.P....................................	Diphtheria and Tetanus Vaccine B.P.
Diphtheria, Tetanus and Pertussis Vaccine B.P.
Tetracycline..................................................	Tetracycline with a buffering agent
Tetracycline with a buffering agent and Amphotericin B.
Tetracycline with a buffering agent and Nystatin B.P.
Thenalidine...................................................	Thenalidine with Calcium Lactobionate
Thenalidine Tartrate......................................	Thenalidine Tartrate with Calcium Lactate B.P. and Calcium Gluconate B.P.
Theobromine, B.P.C......................................	Theobromine B.P.C. with Phenobarbitone B.P.
Thioridazine.................................................	—
Tragacanth, Indian (Gum Karaya)..................	—
Trifluoperazine Hydrochloride.......................	—
Trimeprazine Tartrate, B.P.C.........................	—
Triprolidine Hydrochloride, B.P.C..................	—
Vasopressin..................................................	—
Velactin........................................................	—
Viomycin Pantothenate..................................	Viomycin Sulphate B.P. with Viomycin Pantothenate
Viomycin Sulphate, B.P	Viomycin Sulphate B.P. with Viomycin Pantothenate
Viprynium Embonate....................................	—
Vitamin A.....................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Vitamin D.....................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D

THIRD SCHEDULE Regulation 11.

Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia

Acetazolamide Sodium.	Cajuput Spirit, B.P. 1948.
Acetohexamide.	Calamine Cream Oily, A.P.F.
Acidified Golden Syrup, A.P.F. 1955.	Calcium Aurothiomalate.
Acriflavine, B.P.C.	Calcium Di-Oxytetracycline.
Acrylic Resin.	Calcium Gluconogalactogluconate.
Adrenaline Hydrochloride.	Calcium Lactobionate.
Adrenaline Mucate.	Calcium Phosphate, B.P.C.
Agar, B.P.C. 1954.	Calumba, Concentrated Infusion, B.P. 1948.
Aldosterone.	Calumba Tincture, B.P. 1948.
Alkavervir.	Capsicum Ointment, B.P.C.
Allopurinol.	Capsicum Tincture, B.P.C.
Aloin, B.P.C.	Carbamazepine.
Almond Oil Volatile Bitter, B.P.C. 1959.	Carbarsone, B.P.C.
Aloxidone.	Carbinoxamine Maleate.
Aluminium Acetate Solution, B.P.C.	Cardamom Aromatic Tincture, B.P.C.
Aluminium Hydroxide Mixture, A.P.F.	Catechu Tincture, B.P.C.
Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex.	Cephaloridine.
	Cetomacrogol Emulsifying Wax, B.P.C.
Aluminium Sodium Silicate.	Cetyl Alcohol Compound.
Aluminium Powder, B.P.C.	Chloramine, B.P.C.
Amaranth Solution, A.P.F.	Chloramphenicol Palmitate, B.P.C.
Amaranth Solution, Compound, A.P.F.	Chloramphenicol Stearate.
Amaranth Solution, B.P.C.	Chloramphenicol Succinate.
Aminocaproic Acid.	Chlorazanil Hydrochloride.
Amitriptyline Hydrochloride	Chlorhexidine Diacetate.
Ammonia Aromatic Spirit, B.P.C.	Chlorhexidine Gluconate.
Ammonia Solution Strong, B.P.C.	Chlorobenzol Disulphonamide.
Ammonium Bicarbonate, B.P.C.	Chlorotrianisene, B.P.C.
Ammonium Bromide, B.P.C.	Chlorthalidone, B.P.C.
Amphotericin B.	Cholera El Tor Combined Vaccine.
Angiotensin Amide.	Choline Theophyllinate, B.P.C.
Antazoline Methanesulphonate, B.P.C.	Cinnamon Spirit, B.P.C. 1949.
Antazoline Sulphate.	Cinnamon Water, Concentrated, B.P.C.
Attapulgite.	Clemizole Hydrochloride.
Aurothioglucose.	Clemizole Tannate.
Azathioprine.	Clopamide.
Beclamide.	Clove Concentrated Infusion, B.P.C. 1954.

Beeswax, Yellow, B.P.C.	Coal Tar, B.P.C.
Belladonna Suppository, B.P. 1948.	Cochineal Tincture, B.P. 1948.
Benedict’s Solution, A.P.F.	Coconut Oil, B.P.C. 1949.
Benzalkonium Chloride.	Codeine, B.P.C. 1954.
Benzoin, B.P.C.	Copper Sulphate, B.P.C.
Benzoinated Lard, B.P.C. 1954.	Creosote, B.P.C. 1959.
Benzoin Compound Tincture, B.P.C.	Cudbear Tincture, A.P.F. 1947.
Benzoin Tincture, B.P.C.	Curd Soap, B.P.C.
Benzylpenicillin in Oil.	Cyclopenthiazide.
Bephenium Hydroxynaphthoate, B.P.C.	Cyclothiazide.
Betamethasone Disodium Phosphate.	Cycrimine Hydrochloride.
Betamethasone Phosphate.	Cymogran.
Bethanidine Sulphate.	Cyproheptadine Hydrochloride.
Biperiden Hydrochloride.	Death Adder Antivenene.
Bismuth Subgallate, B.P.C.	Demecarium Bromide.
Bretylium Tosylate.	Deoxycortone Glucoside.
Brompheniramine Maleate.	Desferrioxamine.
Brown Snake Antivenene.	Deslanoside.
Buchu Concentrated Infusion, B.P.C. 1954.	Dexamethasone Sodium Phosphate.
Butabarbital Sodium.	Dexchlorpheniramine Maleate.
Butyl Aminobenzoate, B.P. 1953.	Dextran.
Cade Oil, B.P.C.	Dextriferron.
Caffeine and Sodium Benzoate, B.P.C. 1954.	Diazepam.
Caffeine Citrate, B.P.C. 1959.

Third Schedule—continued

Dicyclomine Hydrochloride, B.P.C.	Hydroxybenzoate Compound Powder, A.P.F.
Digitalis Tincture, B.P.C. 1959.	Hydroxyprogesterone Caproate.
Dihydroergotamine Methanesulphonate.	Hyoscine Methobromide.
Dihydromorphinone Hydrochloride, B.P.C. 1949.	Hypophosphorous Acid, Dilute, B.P.C.
Dihydrostreptomycin Sulphate, B.P. 1958.	Idoxuridine.
Dihydrotachysterol.	Indomethacin.
Dimethicone, B.P.C.	Insulin Injection, specially purified.
Dimethindene Maleate.	Insulin Injection, Biphasic.
Diphenylpyraline Hydrochloride.	Insulin Injection, Neutral.
Dipyridamole.	Insulin Isophane Injection, specially purified.
Disodium Stilboestrol Diphosphate.	Insulin Injection, Special P (Pig).
Dithiazine Iodide.	Iodochlorhydroxyquinoline.
Dyflos, B.P.C.	Iodoform, B.P.C. 1954.
Ecothiopate Iodide.	Iron Aminoates.
Entsufon.	Iron Dextran.
Ephedrine, B.P.C.	Iron Oxide Saccharated.
Ergot, Liquid Extract, B.P. 1914.	Iron Polymaltose Complex.
Erythrityl Tetranitrate.	Iron Sorbitol Complex.
Erythromycin Ethyl Succinate.	Isoprenaline Hydrochloride.
Erythromycin Glucoheptonate.	Isopropamide Iodide.
Erythromycin Lactobionate.	Isothipendyl Hydrochloride, B.P.C.
Erythromycin Stearate.	Kanamycin Sulphate, B.P.C.
Ethacrynic Acid.	Kitasamycin.
Ethanolamine, B.P.C.	Lanatoside-C.
Ethanolamine Oleate.	Lavender Spike Oil, B.P.C.
Ether Nitrous Spirit, B.P.C. 1959.	Lemon Tincture, B.P. 1958.
Ethionamide.	Lincomycin Hydrochloride.
Ethoxzolamide.	Lipopancreatin.
Ethylidene Dicoumarin.	Lissapol.
Ethylnoradrenaline Hydrochloride.	Lobelia Ethereal Tincture, B.P.C.
Ethyloestrenol	Lofenalac.
Eucalyptol, B.P.C.	Lypressin.
Extract of Ox Bile, B.P. 1948.	Magenta, B.P.C.
Ferric Hydroxide.	Magnesium-Aluminium Hydroxide.
Ferrous Aminoacetosulphate.	Magnesium Chloride.
Ferrous Carbonate Saccharated, B.P.C. 1959.	Magnesium Hydroxide, B.P.C.
Ferrous Phosphate Compound Syrup, B.P.C.	Mebhydrolin Napadisylate, B.P.C.
Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C.	Medroxyprogesterone Acetate.
Ferrous Succinate.	Melphalan.
Fluorouracil Sodium.	Mepenzolate Bromide.
Folinic Acid.	Mercaptomerin Sodium.
Framycetin Sulphate.	Mercuric Chloride, B.P.C.
Frusemide.	Mestanolone.
Fusidic Acid, Diethanolamine Salt.	Metaraminol Bitartrate.
Galactomin.	Metformin Hydrochloride.
Gall and Opium Ointment, B.P.C.	Methacycline.
Gelsemium Tincture, B.P.C.	Methazolamide.
Glucagon Hydrochloride.	Methdilazine Hydrochloride.
Glucose Indicator.	Methenamine Mandelate.
Glycerophosphate Compound Syrup, A.P.F.	Methenolone Acetate.
Glyceryl Guaiacolate.	Methotrexate.
Glycopyrronium Bromide.	Methoxamine Hydrochloride, B.P.C.
Glymidine.	Methsuximide.
Goats Milk, dehydrated.	Methyclothiazide.
Gramicidin.	Methyl Glucamine.
Hamamelis Dry Extract, B.P.C.	Methylphenobarbitone, B.P.C.
Hamamelis Liquid Extract, B.P.C.	Methylprednisolone Acetate.
Heparin Retard.	Metyrapone.
Hexocyclium Methylsulphate.	Minafen.
Honey, Purified, B.P.C.	Morphine Tartrate.
Hydrargaphen.	Myrrh Gum, Powdered, B.P.C.
Hydrocyanic Acid, Dilute, B.P.C. 1954.

Third Schedule—continued

Myrrh Tincture, B.P.C.	Potable Water.
Nalidixic Acid.	Potassium Chlorate, B.P.C.
Nandrolone Decanoate.	Potassium, Effervescent Tablets.
Natamycin.	Prednisolone Sodium Hemisuccinate.
Neutramigen.	Prednisolone Sodium Hemisulphate.
Niclosamide.	Prednisolone Sodium Phosphate, B.P.C.
Nicotinyl Alcohol Tartrate.	Prednisolone Tertiary Butyl Acetate.
Nicoumalone.	Propranolol Hydrochloride.
Nitromin.	Protoveratrine A.
Nortriptyline Hydrochloride.	Pumilio Pine Oil, B.P.C.
Nux Vomica, Dry Extract, B.P.C.	Pyrazinamide.
Oestradiol Dipropionate, B.P.C. 1954.	Pyridine Aldoxime Methiodide.
Oestrone, B.P.C. 1954.	Quillaia Tincture, B.P.C.
Oily Ophthalmic Vehicle, A.P.F. 1955.	Quinethazone.
Orange Peel Compound, Concentrated Infusion, B.P.C. 1954.	Raspberry Syrup, B.P.C.
Orange Peel, Concentrated Infusion, B.P.C.	Rauwolfia Alkaloids.
Orciprenaline Sulphate.	Red Back Spider Antivenene.
Oxycodone Pectinate.	Rolitetracycline.
Oxymel, B.P.C.	Rosemary Oil, B.P.C.
Oxymel of Squill, B.P.C.	Salicylamide.
Oxymesterone.	Senega, Concentrated Infusion, B.P.C.
Oxyphencyclimine Hydrochloride.	Senna Compound Mixture, B.P.C. 1959.
Oxyphenonium Bromide.	Senna, Concentrated Infusion, B.P.C. 1959.
Oxytetracycline.	Senna Fruit Extract (Standardised).
Oxytocin.	Siberian Fir Oil, B.P.C. 1949.
Pancreatin Enzyme, U.S.N.F. XI.	Silver Protein, B.P.C.
Papaveretum, B.P.C.	Silver Protein Mild, B.P.C.
Papuan Black Snake Antivenene.	Sobee.
Para-Aminosalicylic Acid.	Sodium Carbonate Anhydrous, B.P.C.
Paraben Ophthalmic Phosphate Buffer, A.P.F. 1955.	Sodium Edetate, B.P.C.
Paraben Ophthalmic Vehicle, A.P.F. 1955.	Sodium Folate.
Paraffin Liquid Light, B.P.C.	Sodium Lactate.
Paramethasone Acetate.	Sodium Nitrite, B.P.C.
Pargyline Hydrochloride.	Sodium Potassium Tartrate, B.P.C.
Pectin.	Sodium Tauroglycocholate, B.P.C. 1954.
d-Penicillamine Hydrochloride, B.P.C.	Spearmint Oil, B.P.C.
Penicillinase.	Spiramycin.
Penicillin, Benethamine, B.P.C.	Squill Tincture, B.P.C.
Pentaerythritol Tetranitrate, diluted, B.P.C.	Stanolone.
Penthienate Methobromide.	Stanozolol.
Peru Balsam, B.P.C.	Stearic Acid, B.P.C.
Phenazone, B.P.C.	Storax, Prepared, B.P.C.
Phenazopyridine Hydrochloride.	Strophanthus Tincture, B.P. 1948.
Phenethicillin Potassium.	Strychnine, B.P.C. 1959.
Phenformin Hydrochloride.	Sulphacetamide, B.P.C.
Pheniramine Maleate.	Sulphadiazine Sodium, B.P.C.
Pheniramine Para-Aminosalicylate.	Sulphadimethoxine, B.P.C.
Phenol Ointment, B.P. 1948.	Sulphaguanidine, B.P.C.
Phenoxymethylpenicillin, Benzathine.	Sulphamerazine, B.P. 1958.
Phenoxymethylpenicillin, Hydrabamine.	Sulphamethoxazole.
Phensuximide.	Sulphamethoxydiazine.
Phenthimentonium.	Sulphaphenazole, B.P.C.
Phenytoin.	Sulphasalazine.
Phthalylsulphacetamide.	Sulphathiazole, B.P.C.
Physostigmine, B.P.C.	Sulphinpyrazone, B.P.C.
Pilocarpine Hydrochloride.	Sulphomyxin Sodium.
Pipenzolate Methobromide.	Sulphurated Potash, B.P.C.
Pituitary (Posterior Lobe) Powdered, B.P.C.	Sulphuric Acid, Dilute, B.P.C.
Polyoestradiol Phosphate.	Sulphur Sublimed, B.P.C.
Polythiazide.	Sultiame.
Surgical Cement.

Third Schedule—continued

Surgical Cement Solvent.	Trasylol.
Sustanon.	Tretamine.
Syrup Glucose Liquid, B.P.C.	Triamcinolone, B.P.C.
Tacrine.	Triamterene.
Taipan Antivenene.	Tricyclamol Chloride.
Tar Ointment, B.P.C. 1959.	Tridihexethyl Chloride.
Tartrazine, B.P.C. 1954.	Triethanolamine, B.P.C.
Testosterone Oenanthate.	Trimeprazine Tartrate, B.P.C.
Tetanus Immune Globulin (Human).	Trinitrophenol, B.P.C. 1959.
Tetracycline.	Triprolidine Hydrochloride, B.P.C.
Thenalidine.	Trolnitrate Phosphate.
Thenalidine Tartrate.	Vadrine.
Theobromine, B.P.C.	Valerian Ammoniated Tincture, B.P.C.
Theobromine and Sodium Salicylate, B.P. 1953.	Vanillin.
Theophylline Ethanoate of Piperazine.	Vasopressin Tannate.
Thiethylperazine.	Velactin.
Thioridazine.	Vinblastine Sulphate.
Thiotepa.	Vincristine Sulphate.
Thyrotrophin.	Vinegar of Squill, B.P.C.
Tiger Snake Antivenene.	Viomycin Pantothenate.
Titanium Dioxide, B.P.C.	Viprynium Embonate.
Tolu Tincture, B.P.C. 1959.	Vitamin A.
Tragacanth, Indian (Gum Karaya).	Vitamin D.

Fourth Schedule.

4. The Fourth Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended by inserting after the words—

“ Citronella Oil, B.P.C.”

the words—

“ Maize Oil, B.P.”.

FifthSchedule.

5. The Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations is repealed and the following Schedule inserted in its stead:—

__________

 

FIFTH SCHEDULE Regulation 14.

Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Acetylsalicylic Acid Tablets, B.P...............................................................................................
Soluble Acetylsalicylic Acid Tablets B.P.
Compound Acetylsalicylic Acid Tablets, A.P.F.	Any disease or condition in a pensioner
Compound Acetylsalicylic Acid Tablets, B.P.C.
Soluble Compound Acetylsalicylic Acid Tablets
Acrylic Resin............................................................................................
	Ileostomy or colostomy conditions
Aldosterone................................................................................................	With the written authority of the Director-General, treatment of an acute crisis in—
	Addison’s disease
	Salt-losing congenital adrenal hypoplasia
Allopurinol...............................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Aminocaproic Acid...............................................................................................

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Amitriptyline Hydrochloride............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Amphetamine Sulphate Tablets, B.P.................	Any disease or condition in a pensioner
Amphotericin B...............................................	Systemic fungal infection
Ampicillin Capsules, B.P.................................	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Ampicillin is the only appropriate antibiotic
Ampicillin Injections.......................................
Ampicillin Tablets...........................................
Aneurine Hydrochloride Tablets, B.P................	Any disease or condition in a pensioner
Angiotensin Amide..........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Ascorbic Acid Tablets, B.P..............................		Any disease or condition in a pensioner
Azathioprine...................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Beclamide.......................................................
Betamethasone Tablets....................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets except cerebral tumors and cerebral oedema
Betamethasone Disodium Phosphate Injection...		Intra-articular use
Busulphan Tablets, B.P....................................		Leukaemia
Any disease or condition in a pensioner
Calciferol Tablets, B.P.....................................	With the written authority of the Director-General—
Calciferol, B.P.................................................	Hypoparathyroidism
Chronic hypoparathyroid tetany
Vitamin D-resistant rickets
Calcium Aminosalicylate.................................	Tuberculosis
Calcium Gluconogalactogluconate Effervescent Tablets.........................................................	Hypoparathyroidism
Carbamazepine................................................	Epilepsy
Trigeminal neuralgia
Cephaloridine..................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Chlorambucil Tablets, B.P...............................	Malignant lymphoma and related conditions
Chloramine Deodorant Tablets and Powder.......	Ileostomy or colostomy conditions
Chloramphenicol Capsules, B.P........................	Bacterial meningitis
Haemophilus influenzae infections
Intra-ocular infections
Rickettsial infections
Salmonella septicaemia
Typhoid and paratyphoid
Other serious infections sensitive only to Chloramphenicol

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Chloramphenicol Injections..............................	A disease or condition specified in this column in relation to Chloramphenicol Capsules
Chloramphenicol Tablets.................................
Chloramphenicol Oral Suspension....................
Chlorotrianisene Tablets..................................	Carcinoma of the prostate
Chlorpromazine Hydrochloride........................	Any disease or condition of a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness
Huntington’s chorea
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital.
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride, or Nortriptyline Hydrochloride
Chlortetracycline Capsules, B.P........................	Brucellosis
Herpes zoster ophthalmicus
Intestinal amoebiasis
Leptospirosis
Lymphogranuloma venereum
Psittacosis
Rickettsial infections
Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins
Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
Chlortetracycline Hydrochloride Granules........	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Choline Theophyllinate....................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Cloxacillin Sodium, B.P...................................
Cloxacillin Capsules, B.P.................................
Compound Codeine Tablets, B.P......................	Any disease or condition in a pensioner
Compound Codeine Soluble Tablets, B.P..........
Codeine Phosphate with Acetylsalicylic Acid Soluble Tablets...............................................
Codeine Phosphate with Acetylsalicylic Acid Tablets.........................................................
Codeine Phosphate with Acetylsalicylic Acid and Phenacetin Tablets.................................
Codeine Phosphate with Acetylsalicylic Acid, Phenacetin and Caffeine Tablets....................
Cod Liver Oil Emulsion...................................	Any disease or condition in a child under the age of twelve years or in a pensioner

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
With the written authority of the Director-General—
Corticotrophin Injection, B.P.............................	A disease or condition specified in this column in relation to Cortisone Injection
Corticotrophin Gelatin Injection, B.P.
Hypsarrhythmia
Corticotrophin Zinc Hydroxide Injection, B.P.	Salaam convulsions
The prevention of side effects of corticosteroid therapy
Cortisone Injection, B.P.	With the written authority of the Director-General—
Anaemia, acquired haemolytic
Addison’s disease
Adrenocortical hypoplasia
Adrenalectomy, total
Adrenogenital syndrome
Agranulocytosis
Behcet’s syndrome
Cranial arteritis
Cushing’s syndrome, including hyperadrenocorticalism
Dermatitis, acute exfoliative
Dermatomyositis
Encephalomyelitis
Encephalomyelitis, acute disseminated
Guillain-Barré syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen’s disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
Hodgkin’s disease
Idiopathic hypercalcaemia
Inflammatory conditions of the uveal tract and retina
Keratoplasty
Leucine-sensitive hypoglycaemia
Leukaemia
Lymphosarcoma and follicular lymphoma
Metastatic breast cancer
Mycosis fungoides
Nephrosis or nephrotic syndrome
Neuromyelitis optica
Optic neuritis following removal of tumor of the brain
Panhypopituitarism
Pemphigus
Periarteritis nodosa
Progressive transverse myelitis
Pseudohermaphroditism
Purpura, Henoch’s
Purpura, thrombocytopenic
Regional ileitis (Crohn’s disease)
Recticulum cell sarcoma
Rheumatic carditis, acute
Sarcoidosis
Scleroderma
Severe reactions of the skin and mucosa following X-ray therapy
Splenic neutropenia
Status asthmaticus
Steroid therapy prior to operation in patients under steroid therapy
Stevens-Johnson syndrome
Still’s disease in a child under the age of sixteen years

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Cortisone Injection, B.P.—continued	Sympathetic ophthalmitis
Systemic lupus erythematosus
Temporal arteritis
Tropical and non-tropical spine and all forms of malabsorption associated with those diseases
Type II Nephritis

Ulcerative colitis proven by sigmoidscopy or radiological report
Cortisone Tablets, B.P............................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Established megalocytic anaemia
Cyanocobalamin Injection, B.P...............	Neuroblastoma
Subacute combined degeneration of the cord
Cymogran.............................................	With the written authority of the Director-General, phenylketonuria
Cycloserine, B.P....................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Cycloserine Capsules, B.P......................
Demethylchlortetracycline Capsules, B.P.
Demethylchlortetracycline Hydrochloride Oral Paediatric Drops and Oral Suspension	A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus
Demethylchlortetracycline Hydrochloride with Nystatin	Any disease or condition specified in this column in relation to Oxytetracycline Hydrochloride with a buffering agent and Nystatin
Deodorant Detergent Solution (Lissapol with Spearmint Oil and Cetrimide)	Ileostomy or colostomy conditions
Deoxycortone Aqueous Injections
Deoxycortone Acetate Injection, B.P.
Deoxycortone Trimethylacetate Injection, B.P.	Addison’s disease
Deoxycortone Acetate Implants, B.P.	Adrenalectomy, total
Deoxycortone Acetate Tablets................
Desferrioxamine....................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Dexamethasone Tablets, B.P...................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets except cerebral tumors and cerebral oedema
Dexamethasone Sodium Phosphate Injections	Intra-articular use
Dexamphetamine Tablets, B.P................	Any disease or condition in a pensioner
Diazepam..............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Dienoestrol Cream.................................	Any disease or condition in a pensioner
Dienoestrol Tablets, B.P.........................	Carcinoma of the prostate
Mammary carcinoma
Any disease or condition in a pensioner
Dihydrostreptomycin Sulphate Injection	As an alternative to Streptomycin Sulphate in the case of a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate
Dihydrotachysterol.................................	Parathyroid deficiency
Diloxanide Furoate Tablets, B.P..............	Amoebic dysentery
Dimethicone..........................................	Ileostomy or colostomy conditions
Disodium Stilboestrol Diphosphate	Carcinoma of the prostate
Dithiazanine Iodide................................	Infestations of Trichuris trichiura or Strongyloides stercoralis

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Ditophal.................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Erythromycin.........................................	Mycoplasma pneumoniae (Eaton’s Agent).
Staphylococcol septicaemia or staphylococcol pneumonia.
A disease or condition specified in this column in relation to Chlortetracycline Capsules—except herpes zoster ophthalmicus
Ethinyloestradiol Tablets, B.P.................	Any disease or condition in a pensioner
Hereditary telangiectasis
Pre-menopausal castration syndrome
Turner’s syndrome
Ethionamide...........................................	Tuberculosis
Ethisterone Tablets, B.P..........................	Turner’s syndrome
Ethyloestrenol........................................	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Fludrocortisone Tablets, B.P...................	Addison’s disease
Adrenocortical hypoplasia
Total adrenalectomy
Fluorouracil Sodium...............................	Carcinoma of the colon and rectum
Fluoxymesterone Tablets, B.P.................	Castration syndrome (male)
Mammary carcinoma
With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Folic Acid Injection................................	Macrocytic anaemia
Folic Acid Tablets, B.P...........................	Sprue or the sprue-like syndrome
Folinic Acid...........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Framycetin Sulphate Tablets...................	Bowel sterilization preparatory to major surgery
Fusidic Acid (Sodium Salt or Diethanolamine Salt)	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Fusidic Acid (Sodium Salt or Diethanolamine Salt) is the only appropriate antibiotic
Galactomin............................................	With the written authority of the Director-General, galactosaemia
Goats Milk, dehydrated...........................	With the written authority of the Director-General, cows milk allergy in children under the age of four years
Griseofulvin Tablets, B.P........................	With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination
Halibut Liver Oil Capsules......................	Any disease or condition in a pensioner
Hexachlorophane with Entsufon..............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Hexachlorophane with Lissapol...............
Hexachlorophane in Soap Solution
Hydrocortisone Injection.........................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Hydrocortisone Acetate Injection, B.P.	Intra-articular use
Hydrocortisone Sodium Succinate Injection	Acute adrenal failure due to medical or surgical crises
Stevens-Johnson syndrome
Hydrocortisone Sodium Succinate Soluble Tablet	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Established megalocytic anaemia
Hydroxocobalamin Injection, B.P	Neuroblastoma
Sub-acute combined degeneration of the cord
Habitual abortion
Hydroxyprogesterone Caproate..............	Progesterone deficiency proven by hormonal assay of lateral wall smear
Idoxuridine.............................................................			Infections caused by Herpes Simplex Virus
Imipramine Tablets, B.P..............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment  of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Isoniazid Tablets, B.P.............................................................	Tuberculosis
Kanamycin Sulphate.............................................................	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the only appropriate antibiotic
Kitasamycin.............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Levorphanol Tartrate.............................................................	Obstetrical use
Severe intractable pain
Lincomycin Hydrochloride.............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Liothyronine Tablets, B.P..............................................................	Myxoedema
Myxoedema coma
Lipopancreatin..............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Lofenalac..............................................................	With the written authority of the Director-General, phenylketonuria
Medroxyprogesterone Acetate Tablets.............................................................	Endometrial carcinoma
Medroxyprogesterone Acetate Injections	Endometrial carcinoma
	Habitual abortion
Progesterone deficiency proven by hormonal assay of lateral wall smear
Melphalan..............................................................	Malignant melanoma
Multiple myeloma
Mercaptopurine Tablets, B.P..............................................................	Allergic angiitis
Leukaemia
Lupus erythematosus
Periarteritis
Mestanolone..............................................................	Mammary carcinoma
With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Methacycline…………………………….	A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whoso treatment it may be prescribed) for supply under Part VII. of the Act
With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
			Methenolone Acetate.............................
Methicillin Sodium................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methicillin Injection, B.P.......................
Methotrexate Tablets .............................	Leukaemia and neoplastic disease
Methotrexate Injections .........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methylamphetamine Injection,B.P.	Any disease or condition in a pensioner
Methylamphetamine Tablets, B.P.
Metyrapone...........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Minafen ................................................	With the written authority of the Director-General, phenylketonuria
Morphine Sulphate, B.P. with Tacrine Tablets	Severe intractable pain
Mustine Hydrochloride Injection ............	Malignant lymphoma and related conditions
Nalidixic Acid.......................................	With the written authority of the Director-General, urinary tract infections
Nandrolone Phenylpropionate Injection, B.P.	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Nandrolone Decanoate...........................
Neomycin Tablets, B.P...........................	Bowel sterilization preparatory to major surgery
Portal-systematic encephalopathy
Neutramigen..........................................	With the written authority of the Director-General—
Cows milk allergy in children under the age of four years
Galactosaemia
Lactose intolerance
Fibrocystic disease of the pancreas in children under the age of four years
Nicotinic Acid Tablets, B.P....................	Any disease or condition in a pensioner
Nitrofurantoin Tablets, B.P.....................	Urinary tract infections
Nitrofurantoin Oral Suspension ..
Nitromin...............................................	Malignant lymphoma and related conditions
Nortriptyline Hydrochloride...................	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thiordazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Nystatin Tablets, B.P.............................	Monilia infections
Orciprenaline Sulphate Injection
Orciprenaline Sulphate Solution for Inhalation	Any disease or condition in a patient receiving treatment in or at an approved hospital
Oxycodone Pectinate.............................	Late-stage malignancy

 

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Oxymesterone.................................	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Oxytetracycline Hydrochloride Capsules......................................
Oxytetracycline Tablets, B.P...........	A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
Oxytetracycline Injections...............
Calcium di-Oxytetracycline Oral Suspension
Calcium di-Oxytetracycline Paediatric Drops
Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis
Oxytetracycline Hydrochloride with a buffering agent and Nystatin.........	A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
Pancreatin, B.P...............................	Fibrocystic disease
Pancreatin Enzyme U.S.N.F. XI.......	Pancreatico-duodenectomy
	Pancreatic steatorrhoea
Para-Aminosalicylic Acid...............	Tuberculosis
Paracetamol Suspension..................	Any disease or condition in a pensioner
Paracetamol Tablets, B.P.................
Paramethasone Acetate...................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Paraffin Liquid Emulsion................	Any disease or condition in a pensioner
Paraffin Liquid Emulsion with Phenolphthalein
Pargyline Hydrochloride.................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Penicillamine.................................	With the written authority of the Director-General—
Cystinosis
Cystinuria with calculus formation
Wilson’s Disease (hepatolenticular degeneration)
Penicillin Benzathine Tablets and Capsules......................................	Prevention of recurrent streptococcal infections, including rheumatic fever
Penicillin Benzyl Tablets, B.P.........
Penicillin Benzyl Capsules..............
Benzylpenicillin with Streptomycin Sulphate
Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate......................................	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Pethidine Hydrochloride with Levallorphan Tartrate...................	Obstetrical use
Phenacetin with Codeine Phosphate and Pentobarbitone Sodium..........	Any disease or condition in a pensioner
Phytomenadione Injection, B.P........	Antidote to anticoagulants
Pituitary, Posterior Lobe, Insufflation	Diabetes insipidus
Polymyxin B. Sulphate Injection......	Any disease or condition in a patient receiving treatment in or at an approved hospital
Polyoestradiol Phosphate................	Carcinoma of the prostate
Prednisolone Sodium Phosphate Retention Enema and Suppository.	With the written authority of the Director-General—
	Ulcerative colitis proven by sigmoidoscopy or radiological report
Proctitis proven by sigmoidoscopy

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Prednisolone Tablets, B.P.................	With the written authority of the Director-General—
Nodular non-suppurative panniculitis (Christian-Weber disease)
A disease or condition specified in this column in relation to Cortisone Injection except total adrenalectomy, Addison’s disease or adrenocortical hypoplasia
Cerebral tumors and cerebral oedema
Prednisolone Acetate Injection.........
Prednisolone Methyl Acetate Injections
Prednisolone Tertiary Butyl Acetate Injections	Intra-articular use
Prednisolone Trimethylacetate Injections
Methylprednisolone Tablets, B.P......	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets except cerebral tumors and cerebral oedema
Methylprednisolone Capsules...........
Prednisolone Sodium Hemisuccinate			With the written authority of the Director-General, medical or surgical crises
Prednisone Tablets, B.P...................			With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Progesterone...................................	Habitual abortion
	Progesterone deficiency proven by hormonal assay of lateral wall smear
Propranolol Hydrochloride...............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyrazinamide..................................
Pyridostigmine Injection, B.P...........	Myasthenia gravis
Pyridostigmine Tablets, B.P.............
Pyridoxine Hydrochloride Tablets	Peripheral neuritis due to isoniazid therapy
Radiation sickness
Quinine Bisulphate Tablets, B.P.......
Quinine Dihydrochloride Tablets......
Quinine Hydrochloride Tablets.........

Malaria
Quinine Sulphate Tablets, B.P..........
Riboflavine Tablets..........................
Senna Fruit Extract (Standardised)	Any disease or condition in a pensioner
Sobee..............................................	With the written authority of the Director-General—
Galactosaemia
Lactose intolerance
Milk allergy in children under the age of four years
Sodium Aminosalicylate Tablets, B.P.
Sodium Aminosalicylate Injection	Tuberculosis
Sodium Aminosalicylate Cachets
Sodium Aminosalicylate Granules
Sodium Folate.................................	Macrocytic anaemia
Sprue or the sprue-like syndrome
Spiramycin......................................	Serologically proven active toxoplasmosis
Staphylococcal septicaemia or staphylococcal pneumonia
Any gram-positive bacterial infections where these cannot be treated safely and effectively by sulphonamides or penicillins

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Spironolactone Tablets, B.P..............	With the written authority of the Director-General, to supplement other diuretics when these have proved inadequate
Stanolone........................................	Mammary carcinoma
With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Stanozolol.......................................	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Carcinoma of the prostate
Stilboestrol Injection........................	Mammary carcinoma
Stilboestrol Tablets, B.P...................	Any disease or condition in a pensioner
Hereditary Telangiectasis
Streptomycin Sulphate Injections......	Bacillary dysentery that is resistant to the Sulphonamides
Brucellosis
Chancroid
Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Friedlander bacillus infections
Haemophilus influenzae infections
Plague
Pseudomonas pyocyanea infections
Rat-bite fever (Streptobacillus moniliformis)
Salmonella infections
Surgical conditions of the bowel (pre-operative and post-operative)
Surgical conditions of the thoracic organs
Tuberculosis
Tularaemia
Urinary tract infections that are resistant to the Sulphonamides
Sulphasalazine.................................	Ulcerative colitis
Sulphomyxin Sodium.......................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Sultiame..........................................	For use where other anticonvulsants have failed
Surgical Cement..............................
Surgical Cement Solvent..................	Ileostomy or colostomy conditions
Sustanon.........................................
Testosterone Implants, B.P...............
Testosterone Oenanthate..................	Castration syndrome (male)
Testosterone Propionate Injection, B.P..................................................	Klinfelter Reifenstein Albright syndrome
	Mammary carcinoma
Methyltestosterone Tablets, B.P........
Methyltestosterone, B.P....................
Tetanus Immune Globulin (Human)	With the written authority of the Director-General, where patients are known to be sensitive to horse serum and cattle serum
Tetracycline Capsules, B.P...............
Tetracycline Tablets, B.P..................
Tetracycline Injections.....................	A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
Rolitetracycline................................
Tetracycline Hydrochloride Granules, Paediatric Drops and Syrup
Tetracycline with a buffering agent
Tetracycline with a buffering agent and Amphotericin B	A disease or condition specified in this column in relation to Oxytetracycline Hydrochloride with a buffering agent and Nystatin
Tetracycline with a buffering agent and Nystatin

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Thiambutosine Tablets, B.P...............	Hansen’s disease
Thiethylperazine Tablets and Suppositories	With the written authority of the Director-General—
	Radiation sickness
Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
	Thioridazine Tablets, B.P..................
	Thioridazine.....................................
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Thyrotrophin....................................	Any disease in or condition in a patient receiving treatment in or at an approved hospital
Tragacanth, Indian (Gum Karaya)	Ileostomy or colostomy conditions
Trasylol...........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Tretamine........................................	Malignant lymphoma and related conditions
Triamcinolone..................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets except cerebral tumors and cerebral oedema
Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness
Trifluoperazine Tablets, B.P..............	With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
Trifluoperazine Hydrochloride, B.P.
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Trimetaphan Injection, B.P................	Hypotensive for anaesthesia
Vadrine............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Vasopressin Nasal Spray ..................	Diabetes insipidus

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Velactin...........................................	With the written authority of the Director-General—
Galactosaemia
Lactose intolerance
Milk allergy in children under the age of four years
Vinblastine Sulphate........................	Hodgkin’s disease
Vincristine Sulphate.........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Viomycin Sulphate...........................
Viomycin Sulphate Injection, B.P.	Tuberculosis
Viomycin Sulphate with Viomycin Pantothenate
Vitamin A with Aneurine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D	Any disease or condition in a pensioner

                        

_________________

By Authority: A.J. Arthur Commonwealth Printer, Canberra